TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
MDGL

Madrigal Pharmaceuticals Inc

Healthcare · Biotechnology

513.20$ +0.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Madrigal Pharmaceuticals Inc (MDGL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,245 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MDGL
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
42 41 40 68 63 192 183 492 490 485 480 470 456 442 411 388 340 287 310 328 305 273 223 216 159 363 332 302 238 641 1,082 1,100 1,073 1,042 997 1,015 1,362 1,260 1,227 1,245
41 41 40 68 63 192 183 491 489 485 478 469 455 440 409 387 338 285 308 326 303 272 221 215 157 361 331 302 235 637 1,074 1,092 1,064 1,033 988 1,003 1,347 1,246 1,182 1,199
8.4 40 8.2 35 13 149 38 265 38 57 47 73 89 47 67 62 109 54 44 34 49 36 42 53 59 332 113 77 62 100 623 495 233 100 184 186 296 199 232 293
40 40 40 67 62 192 183 490 489 484 478 466 454 439 409 384 336 284 307 324 299 270 220 212 153 359 329 298 232 634 1,059 1,058 999 926 843 797 1,110 984 818 839
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – 0.0 -14 6.9 30 54 61 79 113 134 187 192
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – 0.0 0.9 7.1 8.7 34 55 63 69 75 112 99
0.0 0.0 0.0 0.1 0.1 0.3 0.3 0.3 0.2 0.2 0.2 0.2 0.2 1.2 1.4 1.3 1.2 1.0 1.0 1.9 1.7 1.6 0.8 0.8 0.7 0.6 0.5 0.9 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – 5.0 4.9 4.8 4.7 4.6 4.5 7.5 7.4 7.3 7.2
3.9 4.8 5.9 6.4 8.5 10 6.3 5.4 6.6 8.4 11 13 16 25 26 45 50 47 49 57 70 77 77 133 148 165 182 199 216 235 232 243 296 288 286 319 737 657 684 721
3.9 4.8 5.9 6.4 8.5 10 6.3 5.4 6.6 8.4 10 12 15 25 26 45 49 47 49 57 69 77 77 84 99 116 98 100 100 119 114 125 178 169 167 197 391 310 338 374
– – – – – – – – – – 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.4 0.9 0.8 0.6 0.7 0.4 0.5 0.5 0.5 0.6 0.9 1.0 1.0 1.0 1.1 1.0 1.7 1.0
1.2 0.8 2.8 1.3 1.4 1.9 1.4 0.6 1.0 2.5 4.4 0.4 0.8 1.2 1.1 5.0 6.3 1.0 4.4 1.1 10 21 23 11 19 24 12 18 17 28 22 9.0 46 44 42 38 45 49 61 35
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 0.6 – – – – – – – – – – – – 49 49 49 84 99 115 115 116 117 117 118 118 118 340 340 340 341
38 36 34 62 54 182 177 486 483 477 469 457 440 417 385 343 290 240 261 271 235 196 146 84 11 197 150 104 22 405 851 857 777 754 711 696 626 603 543 524
-68 -75 -81 -90 -98 -106 -113 -119 -128 -139 -154 -174 -195 -223 -259 -308 -366 -425 -478 -540 -603 -667 -725 -796 -877 -963 -1,040 -1,125 -1,224 -1,336 -1,484 -1,636 -1,743 -1,802 -1,875 -1,918 -2,032 -2,090 -2,185 -2,243
8.8 12 12 12 12 13 14 14 15 15 15 15 15 15 15 15 15 15 16 17 17 17 17 17 17 17 18 18 18 20 20 21 22 22 22 22 22 22 29 29

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?